Patents by Inventor Chouaib Tahtaoui

Chouaib Tahtaoui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potentiation of helminth treatment
    Patent number: 11938103
    Abstract: The present invention provides a method of treating liver fluke infections in a mammal in need of such treatment comprising administering an effective amount of diamphenethide in combination with an effective amount of clorsulon.
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: March 26, 2024
    Assignee: Elanco Tiergesundheit AG
    Inventors: Sarah George, Peter Rolfe, Chouaib Tahtaoui
  • N-(2,3-DIHYDRO-1,4-BENZOXAZIN-4-YL)-3-ISOPROPYL-7-(2,3,5-TRIFLUOROPHENYL)BENZO-THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS FOR THE TREATMENT OF HEARTWORM INFECTIONS
    Publication number: 20240059680
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: November 17, 2021
    Publication date: February 22, 2024
    Inventors: Nils GRIEBENOW, Chouaib TAHTAOUI, Pierre DUCRAY, Denise RAGEOT
  • POTENTIATION OF HELMINTH TREATMENT
    Publication number: 20230355566
    Abstract: The present invention provides a method of treating liver fluke infections in a mammal in need of such treatment comprising administering an effective amount of diamphenethide in combination with an effective amount of closantel.
    Type: Application
    Filed: December 17, 2020
    Publication date: November 9, 2023
    Inventors: Peter ROLFE, Sarah GEORGE, Chouaib TAHTAOUI
  • BICYCLIC DERIVATIVES FOR TREATING ENDOPARASITES
    Publication number: 20220242857
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: June 5, 2020
    Publication date: August 4, 2022
    Inventors: Pierre DUCRAY, Francois PAUTRAT, Denise RAGEOT, Chouaib TAHTAOUI
  • BICYCLIC DERIVATIVES
    Publication number: 20220064160
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: December 13, 2019
    Publication date: March 3, 2022
    Inventors: Chouaib Tahtaoui, Denise Rageot, Francois Pautrat, Pierre Ducray
  • BICYCLIC DERIVATIVES
    Publication number: 20220064159
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: December 13, 2019
    Publication date: March 3, 2022
    Inventors: Chouaib Tahtaoui, Denise Rageot, Francois Pautrat, Pierre Ducray
  • POTENTIATION OF HELMINTH TREATMENT
    Publication number: 20220008366
    Abstract: The present invention provides a method of treating liver fluke infections in a mammal in need of such treatment comprising administering an effective amount of diamphenethide in combination with an effective amount of clorsulon.
    Type: Application
    Filed: September 30, 2019
    Publication date: January 13, 2022
    Inventors: Sarah George, Peter Rolfe, Chouaib Tahtaoui
  • NEW BICYCLIC DERIVATIVES
    Publication number: 20200385398
    Abstract: The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 10, 2020
    Inventors: Pierre DUCRAY, Denise RAGEOT, Chouaib TAHTAOUI, Francois PAUTRAT
  • Dihydroisoxazole compound for use in controlling sea lice
    Patent number: 10537549
    Abstract: The present invention provides a dihydroisoxazole of formula: or a salt thereof, for use in the control of sea lice in fish.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: January 21, 2020
    Assignee: Elanco Tiergesundheit AG
    Inventor: Chouaib Tahtaoui
  • Sulfonylaminobenzamide compounds as anthelmintics
    Patent number: 10464889
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: November 5, 2019
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui
  • Heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors
    Patent number: 10370375
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: August 6, 2019
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • DIHYDROISOXAZOLE COMPOUND FOR USE IN CONTROLLING SEA LICE
    Publication number: 20190142795
    Abstract: The present invention provides a dihydroisoxazole of formula: or a salt thereof, for use in the control of sea lice in fish.
    Type: Application
    Filed: May 3, 2017
    Publication date: May 16, 2019
    Inventor: Chouaib Tahtaoui
  • New Compounds
    Publication number: 20180346465
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS
    Publication number: 20180319741
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Application
    Filed: July 17, 2018
    Publication date: November 8, 2018
    Inventors: Noelle Gauvry, Chouaib Tahtaoui
  • Compounds
    Patent number: 10059709
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: August 28, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • Sulfonylaminobenzamide compounds as anthelmintics
    Patent number: 10047040
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: August 14, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui
  • NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS
    Publication number: 20170226053
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Application
    Filed: August 27, 2015
    Publication date: August 10, 2017
    Applicant: Novartis Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui
  • Sulfonylaminobenzamide compounds
    Patent number: 9714219
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: July 25, 2017
    Assignee: NOVARTIS TIERGESUNDHEIT AG
    Inventors: Noelle Gauvry, Francois Pautrat, Jean-Luc Perret, Chouaib Tahtaoui
  • New Compounds
    Publication number: 20170050965
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Application
    Filed: March 25, 2015
    Publication date: February 23, 2017
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • (Hetero) arylacrylamides for the control of ectoparasites
    Patent number: 9491941
    Abstract: The present invention relates to new compounds of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on vertebrates.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: November 15, 2016
    Assignee: NOVARTIS TIERGESUNDHEIT AG
    Inventors: Emilie Dupont, Noelle Gauvry, Steve Nanchen, Chikako Ogawa, Chouaib Tahtaoui